In this RichReport slidecast, Dr. Nick New from Optalysys describes how the company’s optical processing technology delivers accelerated performance for FFTs and Bioinformatics.
Earlier this week, the company raised $3.95 million U.S. dollars from angel investors. Optalysys will use the funds to manufacture the first commercially available high-performance computing processor based on its patented optical processing technology.
“In many industries today, the demand for faster processing far exceeds the capabilities of conventional computing technology,” said Dr. Nick New, CEO of Optalysys. “Until now, only large universities and organizations have had the means to use this kind of computing muscle. Our aim is to make supercomputing levels of processing power accessible to a much wider audience of scientists and researchers – which will promote more rapid advancement in such fields as precision medicine and machine learning, whilst addressing some of the fundamental limitations of conventional computing.”